SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Lifesciences - Quaterly Results

11 Aug 2025 Evaluate
A decrease in the sales to Rs. 790.43 millions was observed for the quarter ended June 2025. The sales stood at Rs. 865.71 millions during the similar quarter previous year.The Net proft of the company remain more or less same to Rs. 51.59  millions from Rs. 64.60 millions ,decline by -20.14%.A decline of 118.46 millions was observed in the OP in the quarter ended June 2025 from 141.96 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 790.43 865.71 -8.70 790.43 865.71 -8.70 3333.71 3000.02 11.12
Other Income 10.09 4.30 134.65 10.09 4.30 134.65 39.46 38.37 2.84
PBIDT 118.46 141.96 -16.55 118.46 141.96 -16.55 481.77 382.68 25.89
Interest 17.33 21.59 -19.73 17.33 21.59 -19.73 78.81 89.02 -11.47
PBDT 101.13 120.37 -15.98 101.13 120.37 -15.98 402.96 293.66 37.22
Depreciation 26.34 25.00 5.36 26.34 25.00 5.36 102.56 102.54 0.02
PBT 74.79 95.37 -21.58 74.79 95.37 -21.58 300.40 191.12 57.18
TAX 23.20 30.77 -24.60 23.20 30.77 -24.60 86.70 60.47 43.38
Deferred Tax 0.70 0.77 -9.09 0.70 0.77 -9.09 -1.41 19.94 -107.07
PAT 51.59 64.60 -20.14 51.59 64.60 -20.14 213.70 130.65 63.57
Equity 30.23 30.23 0.00 30.23 30.23 0.00 30.23 30.23 0.00
PBIDTM(%) 14.99 16.40 -8.61 14.99 16.40 -8.61 14.45 12.76 13.29

Haleos Labs Share Price

1249.90 0.00 (0.00%)
08-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×